Moderna Remains 'Cautious' on Guidance, CEO Bancel Says

The video discusses the company's Q1 performance and decision to maintain current guidance due to uncertainties in transitioning from pandemic to endemic. It highlights a $5 billion sales target for 2023, excluding potential contracts in the US, Japan, Europe, and other regions. The speaker emphasizes ongoing discussions with pharmacy and hospital chains, and government agencies. Despite public perception that COVID is over, governments are preparing for potential fall outbreaks, similar to flu season. The video also addresses the risk of new, more severe variants emerging.

What concerns do governments have regarding COVID-19 as we approach the fall?

What is mentioned about the potential for new variants of the virus?